GV-971
Product overview
China Phase III Clinical Trial
Mechanism of Action
Clinical Guideline
Q&A
Scientific Research Information
GREEN MEMORY
Post-marketing Study
IIR Program
Relevant Literature
Information and Services
Master e-Classes
Typical Case
Case Study
Assessment Scale
Conference Information
News Reports
Pharmacovigilance
Company Website
CN
CN
GV-971
Product overview
China Phase III Clinical Trial
Mechanism of Action
Clinical Guideline
Q&A
Scientific Research Information
GREEN MEMORY
Post-marketing Study
IIR Program
Relevant Literature
Information and Services
Master e-Classes
Typical Case
Case Study
Assessment Scale
Conference Information
News Reports
Pharmacovigilance
Company Website
021-50540520
Information and Services
INFORMATION
Master e-Classes
Typical Case
Case Study
Assessment Scale
Conference Information
News Reports
Pharmacovigilance
Typical Case
Master e-Classes
Typical Case
Case Study
Assessment Scale
Conference Information
News Reports
Pharmacovigilance
Your location：
Home
Information and Services
Typical Case
Sodium Oligomannate Brings New Hope – Sharing the Treatment Process of AD Patients
Release time：2022-06-14
Share to
Previous
Back to list
Next
